Effects of Torilis japonica Extract on DNCB-induced Contact Dermatitis in BALB/c Mice

키워드

참고문헌 (71)

1. Kimber L, "Allergic contact dermatitis", International immunopharmacology, 2(2), pp.201~211 (2002)
2. Sung YY, "Topical application of an ethanol extract prepared from illicium verum suppresses atopic dermatitis in NC", Nga mice, 2012, pp.144, 151~159
3. Takeda K, "Mouse models of allergic diseases", Curr Opin Immunol, 21, pp.660~665 (2009)
4. Leung DY, "New insights into atopic dermatitis", The Journal of clinical investigation, 113(5), pp.651~657 (2004)
5. Leung DY, "Atopic dermatitis", Lancet, 361(9352), pp.151~160 (2003)
6. Nutten S, "Atopic dermatitis: global epidemiology and risk factors", Annals of nutrition & metabolism, 66(suppl 1), pp.8~16 (2015)
7. Boguniewicz M, "Atopic dermatitis : a disease of altered skin barrier and immune dysregulation", Immunological reviews, 242(1), pp.233~246 (2011)
8. Wang IJ, "Environmental risk factors for early infantile atopic dermatitis", Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 18(5), pp.441~447 (2007)
9. Hijnen D, "Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cellattracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis", The Journal of allergy and clinical immunology, 113(2), pp.334~340 (2004)
10. Sher A, "Regulation of immunity to parasites by T cells and T cell-derived cytokines", Annual review of immunology, 10, pp.385~409 (1992)
11. Romagnani S, "Immunologic influences on allergy and the TH1", TH2 balance, 2004, pp.113(3), 395~400
12. Akdis CA, "T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis", The Journal of investigative dermatology, 113(4), pp.628~634 (1999)
13. Hasbold J, "Integrating signals from IFN-gamma and IL-4by B cells : positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE and IgG2a", Journal of immunology, 163(8), pp.4175~4181 (1999)
14. Izuhara K, "Signal transduction via the interleukin-4 receptor and its correlation with atopy", International journal of molecular medicine, 3(1), pp.3~10 (1999)
15. Galli SJ, "IgE and mast cells in allergic disease", Nature medicine, 18(5), pp.693~704 (2012)
16. Urb M, "The role of mast cells in the defence against pathogens", PLoS pathogens, 8(4), pp.e1002619~ (2012)
17. Weller K, "Mast cells are required for normal healing of skin wounds in mice", FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 20(13), pp.2366~2368 (2006)
18. Amin K, "The role of mast cells in allergic inflammation", Respiratory medicine, 106(1), pp.9~14 (2012)
19. Kouro T, "IL-5-and eosinophil-mediated inflammation : from discovery to therapy", International immunology, 21(12), pp.1303~1309 (2009)
20. Simon D, "Eosinophils and atopic dermatitis", Allergy, 59(6), pp.561~570 (2004)
21. Onoue A, "Induction of eosinophil-and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin", Experimental dermatology, 18(12), pp.1036~1043 (2009)
22. Soumelis V, "Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP", Nature immunology, 3(7), pp.673~680 (2002)
23. Takai T, "TSLP expression induced via Toll-like receptor pathways in human keratinocytes", Methods in enzymology, 535, pp.371~387 (2014)
24. Yoo J, "Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin", The Journal of experimental medicine, 202(4), pp.541~549 (2005)
25. Correale CE, "Atopic dermatitis: a review of diagnosis and treatment", American family physician, 60(4), pp.1191~1198 (1999)
26. Herman SM, "Antihistamines in the treatment of dermatitis", Journal of cutaneous medicine and surgery, 7(6), pp.467~473 (2003)
27. Stanbury RM, "Systemic corticosteroid therapy--side effects and their management", The British journal of ophthalmology, 82(6), pp.704~708 (1998)
28. Segal AO, "CSACI position statement : safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults", Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 9(1), pp.24~ (2013)
29. Carr WW, "Topical calcineurin inhibitors for atopic dermatitis : review and treatment recommendations", Paediatric drugs, 15(4), pp.303~310 (2013)
30. Kim GT, "Torilis japonica extract, a new potential EMT suppressor agent by regulation of EGFR signaling pathways", International journal of oncology, 45(4), pp.1673~1679 (2014)
31. Kim SM, "Anti-inflammatory activities of Torilis japonica fruit", The Korean Society of Pharmacognosy, 29(4), pp.384~390 (1998)
32. Kim MS, "Anti-angiogenic activity of torilin, a sesquiterpene compound isolated from Torilis japonica", International journal of cancer, 87(2), pp.269~275 (2000)
33. Kim MS, "Anti-invasive activity of torilin, a sesquiterpene compound isolated from Torilis japonica", Oncology reports, 8(2), pp.359~364 (2001)
34. Cho WI, "Antimicrobial activity of torilin isolated from Torilis japonica fruit against Bacillus subtilis", Journal of food science, 73(2), pp.37~46 (2008)
35. Sone K, "Changes of estrous cycles with aging in female F344", n rats, Japanese Association for Laboratory Animal Science, pp.2007, 56(2)[DOI]
36. Park SJ, "Platycodon grandiflorus alleviates DNCBinduced atopy-like dermatitis in NC", Nga mice, 2012, pp.44(4), 469~474
37. Galli SJ, "The development of allergic inflammation", Nature, 454(7203), pp.445~454 (2008)
38. Petersen LJ, "Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique : characterization of factors influencing histamine releasability", The Journal of allergy and clinical immunology, 97(2), pp.672~679 (1996)
39. Gschwandtner M, "Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model", Allergy, 68(1), pp.37~47 (2013)
40. Minami K, "A chronic model for evaluating the itching associated with allergic conjunctivitis in rats", International immunopharmacology, 4(1), pp.101~108 (2004)
41. Guttman-Yassky E, "New era of biologic therapeutics in atopic dermatitis", Expert opinion on biological therapy, 13(4), pp.549~561 (2013)
42. Hamelmann E, "IL-5-induced airway eosinophilia--the key to asthma?", Immunological reviews, 179, pp.182~191 (2001)
43. Corren J, "Anti-interleukin-5 antibody therapy in asthma and allergies", Current opinion in allergy and clinical immunology, 11(6), pp.565~570 (2011)
44. Oh MH, "IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin", Journal of immunology, 186(12), pp.7232~7242 (2011)
45. Stein ML, "Anti-IL-5(mepolizumab)therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels", The Journal of allergy and clinical immunology, 121(6), pp.1473~1483 (2008)
46. Gittler JK, "Atopic dermatitis results in intrinsic barrier and immune abnormalities : implications for contact dermatitis", J Allergy Clin Immunol, 131, pp.300~313 (2013)
47. Jung M, "Inhibitory effect of 5, 6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-kappaB and STAT activation", Journal of dermatological science, 79(3), pp.252~261 (2015)
48. Kabashima K, "New concept of the pathogenesis of atopic dermatitis : interplay among the barrier, allergy, and pruritus as a trinity", Journal of dermatological science, 70(1), pp.3~11 (2013)
49. Fonacier LS, "Allergic skin diseases", The Journal of allergy and clinical immunology, 125(2 Suppl 2), pp.S138~S149 (2010)
50. Liu FT, "IgE, mast cells, and eosinophils in atopic dermatitis", Clinical reviews in allergy & immunology, 41(3), pp.298~310 (2011)
51. Kalesnikoff J, "New developments in mast cell biology", Nature immunology, 9(11), pp.1215~1223 (2008)
52. Lindstedt KA, "Isolation of mast cell granules", Current protocols in cell biology, 3(Unit 3), pp.16~ (2006)
53. Greaves MW, "Antihistamines in dermatology", Skin pharmacology and physiology, 18(5), pp.220~229 (2005)
54. Imaizumi A, "Effective treatment of pruritus in atopic dermatitis using H1antihistamines(second-generation antihistamines) : changes in blood histamine and tryptase levels", Journal of dermatological science, 33(1), pp.23~29 (2003)
55. Tazawa T, "Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis", Archives of dermatological research, 295(11), pp.459~464 (2004)
56. Yamazaki F, "Overactivation of IL-4-induced activator protein-1 in atopic dermatitis", Journal of dermatological science, 28(3), pp.227~233 (2002)
57. Ackerman SJ, "Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders", Immunology and allergy clinics of North America, 27(3), pp.357~375 (2007)
58. Corren J, "Inhibition of interleukin-5 for the treatment of eosinophilic diseases", Discovery medicine, 13(71), pp.305~312 (2012)
59. Hamid Q, "In vivo expression of IL-12 and IL-13 in atopic dermatitis", The Journal of allergy and clinical immunology, 98(1), pp.225~231 (1996)
60. Wang YH, "Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses", Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 39(6), pp.798~806 (2009)
61. Moran TP, "The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch", Pediatrics, 134(suppl 3), pp.S160~S161 (2014)
62. Alysandratos KD, "Increased affected skin gene expression and serum levels of thymic stromal lymphopoietin in atopic dermatitis", Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 105(5), pp.403~404 (2010)
63. Vestergaard C, "Overproduction of Th2-specific chemokines in NC", Nga mice exhibiting atopic dermatitis-like lesions, 1999, pp.104(8), 1097~1105
64. Saeki H, "Thymus and activation regulated chemokine(TARC)", CCL17 and skin diseases, 2006, pp.43(2), 75~84
65. Shimada Y, "Both Th2and Th1 chemokines(TARC", CCL17, MDC, CXCL9)are elevated in sera from patients with atopic dermatitis, pp.Journal of dermatological science, 2004[DOI]
66. Kakinuma T, "Thymus and activation-regulated chemokine in atopic dermatitis : Serum thymus and activationregulated chemokine level is closely related with disease activity", The Journal of allergy and clinical immunology, 107(3), pp.535~541 (2001)
67. College of Oriental Medicine Compilation Committee of Herbalogy, "Herbalogy", pp.630~631 (2006), Younglimsa
68. Park SM, "The documentary examining of gynecologic symptoms and medical substances of fumigation treatment", Master, pp.2002
69. Sin MG, "Clinical Herbalogy", pp.197~ (1994), Younglimsa
70. 구본석, "사상자(Torilis Fructus)가 섬유아세포의 Procollagen 생합성과Matrix metalloproteinase-I(MMP-1)의 활성에 미치는 영향", 생약학회지, 38(4), pp.349~353 (2007), 한국생약학회
71. Choi JE, "Anti-inflammatory and Antioxidant Effects of Water Extracts of Sasangja-tang(SSJ) and Gami-sasangja-tang (GSJ).", Collection of dissertations Institute of Oriental Medicine Daejeon University, 23(2), pp.7~8 (2015)

관련 논문AI추천